MEDIFAST (NYSE: MED) — Perfil da empresa, notícias e dados financeiros
Medifast promotes health with custom weight-loss plans and meal replacement products supported by a direct-selling model.
MEDIFAST
Medifast (NYSE:MED) is a company focused on promoting health through its custom weight-loss plans and a range of meal replacement products and supportive community. It operates primarily through its direct-selling model, leveraging a network of coaches who guide clients towards achieving their weight-loss and fitness goals. The company's projects and objectives are aligned with enhancing its product portfolio, leveraging technology to improve customer and coach experiences, and expanding its reach both domestically and internationally to make healthy living accessible to more people. Medifast aims to not only assist individuals in weight management but also to foster healthier lifestyles through comprehensive support and education.
Resumo
Operações
Produtos e/ou serviços de MEDIFAST
- OPTAVIA, a personalized weight-loss and health program utilizing coaches and a supportive community.
- Flavors of Home, convenient and healthy meals designed for weight management.
- Essential1: Calorie Burn, a product to boost metabolism featuring green tea and caffeine.
- Medifast Meals, a diverse line of portion-controlled, nutritionally balanced meals and snacks.
- OPTAVIA Fuelings, carefully formulated meals and snacks that support optimal health and weight loss.
- Lean and Green Meals, recipes and meal plans focusing on lean proteins and vegetables.
equipe executiva do MEDIFAST
- Nicholas M. JohnsonCEO & President
- James P. MaloneyChief Financial Officer
- Jonathan Barrett MacKenzieVP of Finance & Chief Accounting Officer
- Steven ZenkerVice President of Investor Relations
- Claudia C. GreningerChief Human Resources Officer
Últimas notícias sobre a MEDIFAST
Histórico de dividendos
Dividendos por ação pagos pela MEDIFAST, por ano fiscal.
| Ano fiscal | Intermediário | Final | Especial | Total |
|---|---|---|---|---|
| FY2023 | — | — | — | $4.9500 |
| FY2022 | — | — | — | $6.5600 |
| FY2021 | — | — | — | $5.6800 |
| FY2020 | — | — | — | $4.5200 |
| FY2019 | — | — | — | $3.3800 |
Principais indicadores financeiros
Resultados divulgados pela MEDIFAST, em USD.
- Cap. de mercado
- 137,3 mi
- Receita (TTM)
- 299,6 mi
- P/L
- —
- LPA (diluído, TTM)
- -3.6
- Dividend yield
- —
- Margem de lucro
- -13.6%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 385,8 mi | -14,2 mi | -18,7 mi | |
| 602,5 mi | 2,9 mi | 2,1 mi | |
| 1,1 bi | 126,4 mi | 99,4 mi | |
| 1,6 bi | 184,8 mi | 143,6 mi |